Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 23, 2014
 
Register | Sign in
Home Page>Products
  Product News
Nanoparticle Synthesis Benefits from Syrris Batch and Flow Reactors
Saturday, September 20, 2014
Simple to assemble, easy-to-use reactors enable temperature, time, mixing and concentrations to be quickly varied.

Seward Secures Strong Environmental Credentials Through ISO14001 Certification
Friday, September 19, 2014
Maximizing recycling and minimizing energy usage and environmental impact.

HORIBA UK Introduces EasyCell® Assistant Digital Cell Imaging System
Friday, September 19, 2014
Fast and affordable automated cell imaging to improve lab productivity.

Bringing Photochemistry to the Bench with Vapourtec Innovation
Friday, September 19, 2014
easy-Photochem - A safe, easy-to-use, compact and affordable package.

Fluidigm’s New Juno™ System Shatters Barriers for SNP Genotyping
Friday, September 19, 2014
New system provides simple workflow, requires minimal amount of sample input and hands-on time.

Tecan Offers NGS Sample Preparation at the Touch of a Button
Friday, September 19, 2014
Tecan’s Freedom EVO NGS workstation to offer robust and reliable automation.

Microvisk: ‘World First’ Medical Device Accredited for European Sales
Friday, September 19, 2014
Solid state technology unique in medical diagnostics.

Pexip® Introduces Infinity Connect
Friday, September 19, 2014
Visual meetings on any device simplified with installable client software supporting major desktop operating systems and all major browsers.

Bruker Launches the First Guaranteed AFM TERS Solution
Friday, September 19, 2014
New Innova-IRIS uniquely addresses challenging TERS research.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 10585
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv